Evolent Health, Inc. EVH
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -12.95% | -42.55% | 58.79% | -1,781.99% | 9.82% |
| Total Depreciation and Amortization | -12.89% | -10.12% | -11.28% | 2,717.84% | -23.02% |
| Total Amortization of Deferred Charges | -11.82% | 21.36% | 11.38% | 17.17% | 31.52% |
| Total Other Non-Cash Items | -16.96% | -19.36% | -82.15% | 1,123.56% | 12.05% |
| Change in Net Operating Assets | 176.63% | 57.29% | 49.96% | 180.53% | -64.10% |
| Cash from Operations | 66.82% | 69.30% | -121.56% | 286.04% | -15.31% |
| Capital Expenditure | 19.54% | 88.65% | 51.07% | 19.86% | -172.42% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -24.24% | 170.75% | -- | 100.00% | 103.64% |
| Cash from Investing | 19.44% | 88.93% | 51.07% | 512.21% | 55.59% |
| Total Debt Issued | -- | -- | -- | -68.75% | -- |
| Total Debt Repaid | 100.00% | -- | -- | -21,598.87% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 96.78% | 75.00% | 60.46% | 81.29% | -5,758.82% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | 100.00% | 62.43% |
| Other Financing Activities | -144.28% | 76.95% | 94.80% | -94.31% | 75.96% |
| Cash from Financing | 89.12% | -23.14% | -103.68% | -195.97% | -364.20% |
| Foreign Exchange rate Adjustments | -89.55% | -230.12% | -2,660.87% | -65.44% | -548.39% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 141.15% | 72.69% | -112.03% | -25.58% | -246.27% |